PIORX
Price
$48.33
Change
-$0.55 (-1.13%)
Updated
Jul 13 closing price
Net Assets
11.17B
VSTSX
Price
$354.42
Change
-$2.83 (-0.79%)
Updated
Jul 13 closing price
Net Assets
2.3T
Interact to see
Advertisement

PIORX vs VSTSX

PIORX vs VSTSX Comparison Chart in %
View a ticker or compare two or three
VS
PIORX vs. VSTSX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PIORX is a Buy and VSTSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 2.3T vs. PIORX (11.2B). VSTSX pays higher dividends than PIORX: VSTSX (1.07) vs PIORX (0.00). PIORX was incepted earlier than VSTSX: PIORX (23 years) vs VSTSX (10 years). PIORX (1.40) is less costly to investors than VSTSX (0.01). PIORX is a more actively managed with annual turnover of: 88.00 vs. VSTSX (3.00). PIORX has a lower initial minimum investment than VSTSX: PIORX (0) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 21.48 vs. PIORX (11.17). VSTSX return over 5 years is better than : 66.56 vs. PIORX (19.58).
PIORXVSTSXPIORX / VSTSX
Total Expense Ratio1.370.0113,700%
Annual Report Gross Expense Ratio1.400.0114,000%
Fund Existence23 years10 years-
Gain YTD10.99011.20598%
Front LoadN/AN/A-
Min. Initial Investment05000000000-
Min. Initial Investment IRAN/AN/A-
Net Assets11.2B2.3T0%
Annual Yield % from dividends0.001.07-
Returns for 1 year11.1721.4852%
Returns for 3 years44.4067.0666%
Returns for 5 years19.5866.5629%
Returns for 10 years48.62239.5320%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PWCIX95.22N/A
N/A
Principal Capital Appreciation Inst
PRLAX24.44N/A
N/A
T. Rowe Price Latin America
PACLX37.66N/A
N/A
T. Rowe Price Capital Appreciation Adv
RLIEX20.52N/A
N/A
Lazard International Equity R6
MCYIX16.37-0.51
-3.02%
NYLI Candriam Emerging Markets Eq Cl I